Primary CNS lymphoma in the real world-Opportunities for improved outcomes in different health settings.
作者信息
Parakh Sagun, Gan Hui K
机构信息
Medical Oncology Department, Austin Health, Heidelberg, Melbourne, Victoria, Australia.
Cancer Therapies and Biology Group, Centre of Research Excellence in Brain Tumours, Olivia Newton-John Cancer Wellness and Research Centre, Austin Hospital, Heidelberg, Melbourne, Victoria, Australia.
出版信息
Neurooncol Pract. 2022 Apr 3;9(3):159-160. doi: 10.1093/nop/npac028. eCollection 2022 May.
Abstract
摘要
相似文献
1
Primary CNS lymphoma in the real world-Opportunities for improved outcomes in different health settings.现实世界中的原发性中枢神经系统淋巴瘤——不同健康环境下改善预后的机会
Neurooncol Pract. 2022 Apr 3;9(3):159-160. doi: 10.1093/nop/npac028. eCollection 2022 May.
2
Outcome of a Real-World Patient Cohort with Secondary CNS Lymphoma Treated with High-Intensity Chemoimmunotherapy and Autologous Stem Cell Transplantation.接受高强度化疗免疫疗法和自体干细胞移植治疗的继发性中枢神经系统淋巴瘤真实世界患者队列的结局
Oncol Res Treat. 2021;44(7-8):375-381. doi: 10.1159/000517531. Epub 2021 Jul 21.
3
Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy for Primary and Secondary Central Nervous System Lymphoma: A Systematic Review of Literature.嵌合抗原受体T细胞（CAR-T细胞）疗法治疗原发性和继发性中枢神经系统淋巴瘤：文献系统综述
Clin Lymphoma Myeloma Leuk. 2023 Jan;23(1):15-21. doi: 10.1016/j.clml.2022.09.008. Epub 2022 Oct 7.
4
Primary central nervous system lymphoma: a real-world comparison of therapy access and outcomes by hospital setting.原发性中枢神经系统淋巴瘤：基于医院环境的治疗可及性与结局的真实世界比较
Neurooncol Pract. 2022 Jan 12;9(3):183-192. doi: 10.1093/nop/npab066. eCollection 2022 May.
5
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.利妥昔单抗治疗原发性中枢神经系统淋巴瘤（HOVON 105/ALLG NHL 24 研究）：一项随机、开放标签、III 期分组研究。
Lancet Oncol. 2019 Feb;20(2):216-228. doi: 10.1016/S1470-2045(18)30747-2. Epub 2019 Jan 7.
6
Controversies in primary CNS lymphoma.原发性中枢神经系统淋巴瘤的争议
Expert Rev Neurother. 2005 Jul;5(4):459-64. doi: 10.1586/14737175.5.4.459.
7
Real-World Data (RWD) on the 3-Year Follow-Up Outcomes of Different CNS Prophylaxis Strategies Across CNS-IPI Risk Groups in Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma.弥漫性大 B 细胞非霍奇金淋巴瘤患者不同中枢神经系统预后指数风险组的不同中枢神经系统预防策略的 3 年随访结局的真实世界数据。
JCO Glob Oncol. 2021 Apr;7:486-494. doi: 10.1200/GO.20.00422.
8
Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France.法国霍奇金淋巴瘤和主要 B 细胞非霍奇金淋巴瘤的真实世界疾病负担。
J Med Econ. 2020 Mar;23(3):235-242. doi: 10.1080/13696998.2019.1702990. Epub 2019 Dec 26.
9
Differences in palliative opportunities across diagnosis groups in children with cancer.癌症患儿不同诊断组之间的姑息治疗机会差异。
Pediatr Blood Cancer. 2023 Jan;70(1):e30081. doi: 10.1002/pbc.30081. Epub 2022 Nov 15.
10
Diagnostic Accuracy of T1-Weighted Dynamic Contrast-Enhanced-MRI and DWI-ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma.T1加权动态对比增强磁共振成像（MRI）和扩散加权成像-表观扩散系数（DWI-ADC）对胶质母细胞瘤和原发性中枢神经系统淋巴瘤鉴别的诊断准确性
AJNR Am J Neuroradiol. 2017 Mar;38(3):485-491. doi: 10.3174/ajnr.A5023. Epub 2016 Dec 8.
引用本文的文献
1
Diagnostics and treatment delay in primary central nervous system lymphoma: What the neurosurgeon should know.原发性中枢神经系统淋巴瘤的诊断和治疗延误：神经外科医生应该知道的。
Acta Neurochir (Wien). 2024 Jun 11;166(1):261. doi: 10.1007/s00701-024-06138-3.
本文引用的文献
1
Primary central nervous system lymphoma: a real-world comparison of therapy access and outcomes by hospital setting.原发性中枢神经系统淋巴瘤：基于医院环境的治疗可及性与结局的真实世界比较
Neurooncol Pract. 2022 Jan 12;9(3):183-192. doi: 10.1093/nop/npab066. eCollection 2022 May.
2
Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate.采用抗逆转录病毒疗法、利妥昔单抗和大剂量甲氨蝶呤治疗HIV相关原发性中枢神经系统淋巴瘤。
Blood. 2020 Nov 5;136(19):2229-2232. doi: 10.1182/blood.2020006048.
3
Therapy and outcomes of primary central nervous system lymphoma in the United States: analysis of the National Cancer Database.美国原发性中枢神经系统淋巴瘤的治疗与结局：国家癌症数据库分析
Blood Adv. 2016 Nov 30;1(2):112-121. doi: 10.1182/bloodadvances.2016000927. eCollection 2016 Dec 13.
4
Long-term AIDS-related PCNSL outcomes with HD-MTX and combined antiretroviral therapy.采用 HD-MTX 和联合抗逆转录病毒疗法的长期艾滋病相关 PCNSL 结局。
Neurology. 2017 Aug 22;89(8):796-804. doi: 10.1212/WNL.0000000000004265. Epub 2017 Jul 26.
5
Long-term survival in AIDS-related primary central nervous system lymphoma.艾滋病相关原发性中枢神经系统淋巴瘤的长期生存情况。
Neuro Oncol. 2017 Jan;19(1):99-108. doi: 10.1093/neuonc/now155. Epub 2016 Aug 30.
6
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.CBTRUS统计报告：2008 - 2012年美国原发性脑和中枢神经系统肿瘤诊断情况
Neuro Oncol. 2015 Oct;17 Suppl 4(Suppl 4):iv1-iv62. doi: 10.1093/neuonc/nov189. Epub 2015 Oct 27.
Zotero 插件